WULF Stock Rallies As AI Power Deals Fuel Bullish Outlook

TeraWulf Inc. stocks have been trading up by 7.71 percent, driven primarily by bullish sentiment on its Bitcoin-mining growth.

Live Update At 12:32:19 EDT: On Friday, September 11, 2026 TeraWulf Inc. stock [NASDAQ: WULF] is trending up by 7.71%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Quick Financial Overview

WULF has been trading like a true momentum name. Over the past few weeks, the stock bounced from the mid‑$14s to recent closes near $17–$18, with 2026/09/11 finishing at $17.385 after a strong intraday grind. That is a solid recovery from the 2026/09/02–2026/09/04 range, when WULF chopped between roughly $14.80 and $16.50.

Intraday, the 5‑minute chart shows steady higher lows from the open around $16.30 toward the midday push above $17.40. For short-term traders, that pattern screams controlled uptrend rather than wild spike. Dips toward $17 kept getting bought, telling you there is real demand under the surface.

Fundamentally, WULF is still a high‑growth, high‑loss story. Quarterly revenue is about $44.8M against a net loss near $940M and EBITDA around -$861M. Margins are deeply negative, but gross margin near 84% shows that once these AI data centers fill, incremental revenue can be very profitable. The balance sheet carries roughly $4.0B in long‑term debt and a current ratio below 1, so liquidity and execution matter. For traders, this is a classic “story stock” where price tends to move more on contracts, power deals, and analyst calls than on current earnings.

Why Traders Are Locked In On WULF

TeraWulf Inc. has quietly morphed from a Bitcoin miner into a leveraged play on AI data infrastructure, and the tape is catching on. WULF is now all about power, contracts, and scale. The headline deal is the 20‑year lease with Anthropic for roughly 401 MW at its repurposed aluminum smelter site, tied to an estimated $19B of contracted revenue. That is not a small side project; it is the core of the WULF story and a big reason shares rerated higher this year.

Layered on top is the Kentucky Public Service Commission approval for up to 482 MW of power at the Justified Data Campus in Hancock County. That agreement supports a potential $4.0–$4.5B AI and high‑performance computing build‑out. Regulators signed off, but WULF assumes the heavy lifting: market risk, transmission, infrastructure spend, and financial guarantees. Traders should read that as “huge upside, very real execution risk.”

On Wall Street, the narrative is aligning around this transformation. William Blair initiated WULF at Outperform with a $31 base‑case value, explicitly calling the recent pullback an attractive entry as backlog becomes contracted revenue and the market assigns a higher multiple. Morgan Stanley trimmed its target from $72 to $62.50 yet kept an Overweight stance, arguing that WULF now looks more like infrastructure than a swingy crypto miner. Freedom Capital came in with a Buy and $19 target while suggesting a valuation floor around $14. Add in Lone Pine boosting its stake, and you have a name where institutions, analysts, and momentum traders are staring at the same chart.

Conclusion

For active traders, WULF sits at the intersection of several powerful themes: AI demand, scarce energized power, and the shift from speculative mining to contracted infrastructure cash flows. The Anthropic lease and Kentucky power deal give TeraWulf Inc. something many high‑beta names lack — multi‑year revenue visibility. At the same time, the financials remind everyone this is far from a safe, mature utility. Losses are heavy, leverage is meaningful, and WULF is assuming big power and build‑out obligations to capture that upside.

That tension is exactly what creates trading opportunity. Analyst targets from Freedom Capital’s $19 up through William Blair’s $31 and Morgan Stanley’s $62.50 show a wide potential range for where WULF might trade as the story plays out. The stock’s recent action — grinding higher on strong news rather than one‑and‑done spikes — tells you there is real two‑sided liquidity for disciplined day and swing trading.

The key is to treat WULF like any fast‑moving story stock: focus on catalysts, manage risk, and never fall in love with a narrative. As Tim Sykes likes to say, “My number‑one rule is cut losses quickly — that’s how you stay in the game long enough to catch the big winners.” Equally important is respecting patience and selectivity; as millionaire penny stock trader and teacher Tim Sykes, says, “There is always another play around the corner; don’t chase just because you feel FOMO.”. For traders watching WULF, that mindset matters more than any price target. This analysis is for educational and research purposes only and is not investment advice.

This is stock news, not investment advice. Timothy Sykes News delivers real-time stock market news focused on key catalysts driving short-term price movements. Our content is tailored for active traders and investors seeking to capitalize on rapid price fluctuations, particularly in volatile sectors like penny stocks. Readers come to us for detailed coverage on earnings reports, mergers, FDA approvals, new contracts, and unusual trading volumes that can trigger significant short-term price action. Some users utilize our news to explain sudden stock movements, while others rely on it for diligent research into potential investment opportunities.

Dive deeper into the world of trading with Timothy Sykes, renowned for his expertise in penny stocks. Explore his top picks and discover the strategies that have propelled him to success with these articles:

• Penny Stocks Trading Guide
• Best Penny Stocks Under $1 to Buy Today
• Top 8 Penny Stocks to Watch on Robinhood

Once you’ve got some stocks on watch, elevate your trading game with StocksToTrade the ultimate platform for traders. With specialized tools for swing and day trading, StocksToTrade will guide you through the market’s twists and turns.
Dig into StocksToTrade’s watchlists here:

• AI Penny Stocks
• Robinhood Penny Stocks
• Top Biotech Stocks